Series A+ Fundraising and Investor Board Dynamics

Seed-stage fundraising, covered in the companion lesson Funding Vehicles, often runs on SAFEs or convertible notes — fast, lightweight instruments that defer most of the hard governance questions. Series A is where that changes: it's typically a real priced round, with institutional venture investors, actual preferred stock with real negotiated rights, a board seat or two for investors, and ongoing governance obligations that didn't exist before. This is the point where "raising money" starts to mean "taking on a real, ongoing governance partner," not just "getting a check."

As of 2026, the median Series A round is roughly $15 million, at a median post-money valuation around $78.7 million — though this varies significantly by sector. Pre-money valuation ranges commonly run $25M–$50M for B2B SaaS, $50M–$150M for AI, and $20M–$40M for fintech. Most Series A investors end up owning roughly 20–25% of the company after the round closes.

Why sector benchmarking matters: comparing your round to an unrelated industry's typical size or valuation can badly mislead your expectations in either direction — an AI company and a traditional SaaS company at "the same stage" can have very different typical Series A profiles.

A liquidation preference determines who gets paid first, and how much, when the company is sold or liquidated. The current market standard — used in roughly 98% of venture deals — is a 1x non-participating preference: in an exit, the investor chooses either to take back their original investment amount first, or to convert to common stock and take their pro-rata share of the proceeds — not both.

Participating preferred stock lets the investor do both: take the preference amount back, and still participate in the remaining proceeds alongside common holders. This directly reduces what founders and employees receive, and it's now considered largely off-market for early-stage deals — roughly 95% of current deals use non-participating terms. If a term sheet proposes participating preferred as a standard term rather than something specifically negotiated for unusual circumstances, that's worth treating as a real red flag to push back on, not a routine formality.

Protective provisions give investors veto rights over specific major company decisions, without requiring a majority ownership stake to have that power. They appear in over 90% of current venture deals, and typically cover things like: selling the company, issuing new equity (which could dilute the investor), amending the certificate of incorporation, and incurring debt above a defined threshold.

Why this isn't really about day-to-day control: protective provisions are narrowly scoped to fundamental, high-stakes decisions — they don't give investors a say in ordinary operating decisions. Their purpose is to prevent the board or founders from unilaterally taking an action that would significantly change the investor's position (like a fire-sale acquisition or issuing a huge new dilutive round) without investor buy-in.

A typical Series A board settles around 5 members: 2 founders, 2 investors, and 1 independent director. The independent director's selection matters more than it might seem — if investors effectively control who fills that seat, the board can function as a 3-2 investor-leaning majority even though it's nominally balanced. Understanding who actually gets to select the independent director, and under what process, is worth real attention when negotiating board composition — it's not just a formality slide in the term sheet.

Information rights typically require the company to provide investors with regular financial statements and other updates on an ongoing basis — a real, recurring operational obligation, not a one-time disclosure. Pro-rata rights give existing investors the right (not obligation) to participate in future funding rounds specifically to maintain their existing ownership percentage — meaning your next round's available allocation for new investors is effectively reduced by however much your existing investors choose to exercise this right.